SMAD2 and oral submucous fibrosis: YBX1 promotes the expression of α-SMA and p-Smad2 along with the progression of human buccal mucosal fibroblasts to myofibroblasts transition in oral submucous fibrosis [30], which correlates with TGF-β signaling pathway.